论文部分内容阅读
子宫肉瘤占子宫恶性肿瘤的3~5%,罕见和多形态特征使治疗的研究和介绍困难。近年来淋巴结切除,辅助放疗和化疗的治疗方式可能改进一般的不良预后。本研究对某地方性癌中心子宫肉瘤疗法进行评价。 99例子宫肉瘤病例诊断来自1970至1985年安大略癌治疗和研究基金会伦敦诊所。资料记录了主诉、过去盆腔放射、诊断过程、临床和外科分期、组织学诊断、外科治疗和辅助放疗或化疗以及复发。最初的图表无资料介绍,后加的回顾是根据医生的记录、其他癌治疗中心的记录、个体医院的图表和电话通知患者。随访是100%。
Uterine sarcoma accounts for 3 to 5% of uterine malignancies, rare and multi-morphological characteristics of the treatment of research and presentation difficulties. In recent years, lymph node dissection, adjuvant radiotherapy and chemotherapy treatment may improve the general adverse prognosis. This study evaluated the treatment of uterine sarcoma at a local cancer center. 99 cases of uterine sarcoma cases diagnosed from 1970 to 1985 Ontario Cancer Treatment and Research Foundation London Clinic. The data records the chief complaint, past pelvic radiology, diagnostic procedures, clinical and surgical staging, histological diagnosis, surgical treatment and adjuvant radiotherapy or chemotherapy, and relapse. The initial chart did not contain an introduction. The latter review was based on records of doctors, records of other cancer treatment centers, individual hospital charts and phone calls. Follow-up was 100%.